Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intra-Aortic Balloon Pumping | 1 | 2026 | 10 | 0.960 |
Why?
|
| Shock, Cardiogenic | 1 | 2026 | 23 | 0.950 |
Why?
|
| Heparin | 1 | 2026 | 116 | 0.930 |
Why?
|
| Heart-Assist Devices | 1 | 2026 | 38 | 0.920 |
Why?
|
| Thrombocytopenia | 1 | 2026 | 118 | 0.880 |
Why?
|
| Anticoagulants | 1 | 2026 | 302 | 0.820 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2025 | 24 | 0.450 |
Why?
|
| Hematologic Neoplasms | 2 | 2025 | 24 | 0.450 |
Why?
|
| Macrophages | 2 | 2025 | 308 | 0.340 |
Why?
|
| Antibodies, Bispecific | 1 | 2025 | 12 | 0.230 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2025 | 18 | 0.230 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2025 | 41 | 0.220 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 56 | 0.220 |
Why?
|
| Thrombosis | 1 | 2026 | 155 | 0.220 |
Why?
|
| Stroke Volume | 1 | 2025 | 125 | 0.210 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 115 | 0.210 |
Why?
|
| Incidence | 1 | 2026 | 581 | 0.210 |
Why?
|
| Hemorrhage | 1 | 2026 | 271 | 0.210 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2025 | 76 | 0.210 |
Why?
|
| Medical Oncology | 1 | 2025 | 99 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 166 | 0.210 |
Why?
|
| Myocardium | 1 | 2025 | 197 | 0.210 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 285 | 0.200 |
Why?
|
| Heart Failure | 1 | 2025 | 254 | 0.180 |
Why?
|
| Monocytes | 1 | 2023 | 135 | 0.180 |
Why?
|
| Risk Factors | 1 | 2026 | 2144 | 0.160 |
Why?
|
| Humans | 5 | 2026 | 29211 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1524 | 0.070 |
Why?
|
| Pharmacovigilance | 1 | 2025 | 4 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2025 | 14 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2025 | 48 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2025 | 32 | 0.060 |
Why?
|
| Receptors, CCR2 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Gene Editing | 1 | 2025 | 27 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2025 | 89 | 0.060 |
Why?
|
| Fibrosis | 1 | 2025 | 145 | 0.050 |
Why?
|
| Mice | 2 | 2025 | 4870 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 415 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 11 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2025 | 311 | 0.050 |
Why?
|
| Kidney | 1 | 2023 | 290 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1260 | 0.040 |
Why?
|
| Animals | 2 | 2025 | 10806 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1684 | 0.040 |
Why?
|
| United States | 1 | 2025 | 2270 | 0.040 |
Why?
|
| Adult | 1 | 2025 | 8130 | 0.020 |
Why?
|
| Male | 1 | 2025 | 14126 | 0.020 |
Why?
|
| Female | 1 | 2025 | 15825 | 0.020 |
Why?
|